CtBP1–LSD1 complex drives ErbB2 activation via H3K9me2 demethylation in DRGs during paclitaxel-induced neuropathic pain
Hsien-Yu Peng, Cheng-Yuan Lai, Gin-Den Chen, Yun-Chih Peng, Chou-Ming Yeh, Tzer-Bin Lin, Hsueh-Hsiao Wang, Jen-Kun Cheng, Po-Sheng Yang, Chia-Man Chou, Dylan Chou, Kuan-Hung Lin, Siao-Tong Nie, Ming-Chun Hsieh · 2025
Read CtBP1–LSD1 complex drives ErbB2 activation via H3K9me2 demethylation in DRGs during paclitaxel-induced neuropathic pain by Hsien-Yu Peng, Cheng-Yuan Lai, Gin-Den Chen, Yun-Chih Peng, Chou-Ming Yeh, Tzer-Bin Lin, Hsueh-Hsiao Wang, Jen-Kun Cheng, Po-Sheng Yang, Chia-Man Chou, Dylan Chou, Kuan-Hung Lin, Siao-Tong Nie, Ming-Chun Hsieh (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12714790.txt.
Description
Hsien-Yu Peng and co-authors trace a gene switch behind chemotherapy nerve pain in a 2025 study. Paclitaxel, a common cancer drug, often causes peripheral nerve pain that caps dosing. A gene-regulating protein rose in spinal nerve hubs after treatment in rats.
That protein partners with an enzyme that strips a silencing mark from one growth gene's promoter. Treatment lifted the protein, boosted the enzyme, and switched the growth gene on in nerve cells. Silencing either partner reversed the gene's rise and eased pain sensitivity. The authors propose blocking this pair as a route to treat chemo-induced nerve pain.
Catalog record
| CREATOR | Hsien-Yu Peng, Cheng-Yuan Lai, Gin-Den Chen, Yun-Chih Peng, Chou-Ming Yeh, Tzer-Bin Lin, Hsueh-Hsiao Wang, Jen-Kun Cheng, Po-Sheng Yang, Chia-Man Chou, Dylan Chou, Kuan-Hung Lin, Siao-Tong Nie, Ming-Chun Hsieh |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |